We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
-8.18%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$63.6M
AUM Growth
-$13.7M
Cap. Flow
-$3.71M
Cap. Flow %
-5.83%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PASG icon
Passage Bio
PASG
+$3.2M
2
ALGS icon
Aligos Therapeutics
ALGS
+$510K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.68B
$23.4M 36.84%
498,558
– –
CTNM
2
Contineum Therapeutics
CTNM
$529M
$17.6M 27.64%
918,163
– –
RPTX
3
DELISTED
Repare Therapeutics
RPTX
$9.1M 14.32%
2,646,657
– –
SKYE icon
4
Skye Bioscience
SKYE
$21.6M
$7.85M 12.35%
2,007,704
– –
ADVM
5
DELISTED
Adverum Biotechnologies
ADVM
$3.56M 5.6%
506,821
– –
GRTS
6
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$2.07M 3.25%
3,561,150
– –
ALGS icon
7
Aligos Therapeutics
ALGS
$26.3M
– –
-58,317
Closed -$510K
PASG icon
8
Passage Bio
PASG
$14.7M
– –
-201,321
Closed -$3.2M

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q3 2024 Portfolio in Review

As of Q3 2024, Versant Venture Management held 8 positions worth $63.6M, down 18% from $77.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management withdrew a net $3.71M in Q3 2024, closing 2 positions. Its most notable exit was Passage Bio, an estimated $3.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management fully exited Passage Bio in Q3 2024, selling an estimated $3.2M.
  • Versant Venture Management's ten largest holdings make up 100% of its $63.6M portfolio in Q3 2024.
  • Versant Venture Management opened 0 new positions and closed 2 in Q3 2024.
  • Versant Venture Management's portfolio value fell 18% quarter-over-quarter to $63.6M.

Based on Versant Venture Management's 13F filing for Q3 2024, filed 8 Nov 2024.